Acute Pulmonary Embolism in Critically Ill Patients with COVID-19
Manjunath, M.; Miranda, J.; Fraenkel, L.; Johansen, P. M.; Phinney, B.; Valli-Harwood, G.; Callahan, C.; Alsmaan, H.; Oelberg, D.
Show abstract
Since the discovery of the novel coronavirus (SARS-Co-V-2) in December 2019, multiple characteristics have been reported, as our understanding of this new disease unfolds. One such association is its tendency to cause thromboembolic events, particularly venous thromboembolism1,2. In a four-week period during the initial spread of COVID-19 at a 300 bed community hospital in western Massachusetts, 23 patients who were PCR positive for SARS-CoV-2 RNA required treatment in either the intensive care unit (ICU) or intermediate/step-down unit (SDU). All patients were treated with standard DVT prophylaxis from the time of admission, except for two patients who were on full anticoagulation for chronic atrial fibrillation. Of the 23 patients, 7 (30%) were diagnosed with acute, clinically significant, pulmonary embolism (PE). Four of the 7 manifested evidence of acute cor pulmonale, one of whom succumbed as a direct consequence of a massive PE. Other markers were reviewed in the 7 patients to identify trends that could allow for early suspicion of PE in COVID-19 patients. Although D-dimer tended to rise during the hospitalization relative to the control group, the results were inconsistent, and there were no other meaningful distinguishing features between the groups at the time of admission.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Early initiation of prophylactic anticoagulation for prevention of COVID-19 mortality: a nationwide cohort study of hospitalized patients in the United States 93%
- Heparin for Moderately Ill Patients with Covid-19 91%
- Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City 87%
Similar papers in this journal
- Venous Thromboembolism and the Effects of Statin and Hormone Therapy: A Case-Control Study of 250,000 Women 50-64 years of age 89%
- Corticosteroids in COVID-19: Optimizing Observational Research through Target Trial Emulations 87%
- Cardiopulmonary exercise testing to evaluate post-acute sequelae of COVID-19 (“Long COVID”): a systematic review and meta-analysis 87%
Similar papers in this journal
Similar papers in this journal
- Clinical Outcomes With the Use of Prophylactic Versus Therapeutic Anticoagulation in COVID-19 90%
- A Multicenter Evaluation of Blood Purification with Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19: A Preliminary Report 90%
- Neutrophil Extracellular Trap Biomarker Titers and Delayed Cerebral Ischemia in Patients With Aneurysmal Subarachnoid Hemorrhage 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.